ATFirst™ · General health rapid tests

ATFirst™ PSA Rapid Test

A qualitative lateral flow cassette for prostate-specific antigen (PSA) in whole blood, serum or plasma, for use by healthcare professionals.

Lateral flow rapid test cassette

Intended use

The ATFirst™ PSA rapid test is a qualitative cassette for professional in vitro diagnostic use. It shows whether prostate-specific antigen in whole blood, serum or plasma is above the level defined in the insert, and supports clinical assessment alongside examination and laboratory findings.

PSA is a protein made by cells of the prostate gland, and a small amount is normally present in the blood of men. Levels can rise with prostate cancer, but also with benign enlargement of the prostate and with prostatitis. A raised PSA is therefore a reason for clinical follow-up, not a diagnosis. The cassette is part of the ATFirst™ rapid tests range distributed by First Diagnostic™ Corporation.

Specifications

BrandATFirst™
Catalog number85226400145
FormatLateral flow cassette
Analyte / targetProstate-specific antigen (PSA)
SpecimenWhole blood, serum or plasma
Pack size20 tests — confirm at quotation
Intended userHealthcare professionals
RegulatoryDocumentation available on request
Instructions for useSupplied with each kit; current insert on request

How the test works

PSA is measured here as an antigen. Antibody against PSA, bound to colored particles, attaches to PSA in the specimen; a second anti-PSA antibody at the test line traps the complex as it passes, as is usual for this test design. Some PSA cassettes carry a reference line in addition to the control line, so the insert must be followed for reading. More on the method: lateral flow tests.

What to confirm in the insert

  • The PSA level at which the test line appears, and the form of PSA measured
  • Specimen handling and sample volume
  • Read window
  • Storage conditions and shelf life
  • Interpretation of line intensity, if the insert uses it

The insert supplied with each kit defines all of these and is available on request from sales@firstdiagnostic.com. See the product inserts page for inserts already published.

Limitations

  • The test does not diagnose or rule out prostate cancer and is not a population screening tool.
  • It reports no PSA value, so it cannot be used to follow PSA over time. Use a quantitative laboratory assay where a value is needed.
  • Urinary infection, catheterization and prostate biopsy can raise PSA; some medicines for prostate enlargement lower it.
  • A negative result does not exclude prostate disease.

Frequently asked questions

No. It is a qualitative visual test.

Healthcare professionals only. The product is for professional in vitro diagnostic use.

Whole blood, serum or plasma; 20 tests per kit; catalog number 85226400145, confirmed at quotation. Distributors: see the distributor application.

Request PSA rapid test pricing

Tell us the quantity and the country of use. Regulatory documentation is available on request.

Regulatory status: Products shown on this website are for professional in vitro diagnostic use. They are not cleared, approved or authorized by the U.S. Food and Drug Administration and are not offered for sale in the United States. Product availability and regulatory status vary by country; contact us for the status in your market.